U.S. Venture Partners
Menlo Park, Californiausvp.com
Overview
U.S. Venture Partners is a leading Silicon Valley venture capital firm, partnering with entrepreneurs to transform their ideas into world-changing companies. USVP focuses on early-stage start-ups that transform cybersecurity, enterprise software, consumer and healthcare.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cagent Vascular | May 2026 | Series D | Lead |
| Nervonik | Apr 2026 | Series B | Co-investor |
| Route 92 Medical | Apr 2026 | Series F Extension | Co-investor |
| Slang.ai | Feb 2026 | Series B | Lead |
| Adaptive6 | Jan 2026 | Series A | Lead |
Key People
Jacques Benkoski
General Partner
Jonathan Root
General Partner
Matthew Garratt
General Partner
Paul Matteucci
General Partner
Rick Lewis
General Partner
Steve Krausz
General Partner
Irwin Federman
Partner
Dafina Toncheva
Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.